Article and Video CATEGORIES
Chief of Hematology/Oncology and Medical Director at Memorial Cancer Institute, and Clinical Associate Professor of Medicine at Florida International University
Chief of Hematology/Oncology
Medical Director of Memorial Cancer Institute
We are pleased to offer more additions to our Lung Cancer Video Library for our Spanish speaking community.
Translating Molecular Oncology Results into Targeted Therapy Treatment
For the newest additions to our Lung Cancer Video Library, produced in Spanish for our Latino Community, Dr. Luis E. Raez provides us with the latest information in lung cancer care.
In this video, Dr. Raez discusses translating molecular oncology results into targeted therapy treatments in precision medicine.
*****
Avances en Biologia Molecular Convirtiendose en Sucessos de Terapia Blanco Medicina de Precis
Para conocer las adiciones más recientes a nuestra Biblioteca de videos sobre cáncer de pulmón, producida en español para nuestra comunidad latina, el Dr. Luis E. Raez nos brinda la información más reciente sobre el cuidado del cáncer de pulmón.
En este video, el Dr. Raez analiza la traducción de los resultados de la oncología molecular en tratamientos de terapia dirigida en la medicina de precisión. Para unirse a la conversación, visite https://cancergrace.org/forum.
*****
To join the conversation, visit https://cancergrace.org/forum.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…